198 related articles for article (PubMed ID: 35839027)
1. Effect of azithromycin on bronchiolitis obliterans syndrome in posttransplant recipients: A systematic review and meta-analysis.
Hao X; Peng C; Lian W; Liu H; Fu G
Medicine (Baltimore); 2022 Jul; 101(28):e29160. PubMed ID: 35839027
[TBL] [Abstract][Full Text] [Related]
2. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.
Porhownik NR; Batobara W; Kepron W; Unruh HW; Bshouty Z
Can Respir J; 2008; 15(4):199-202. PubMed ID: 18551201
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
Kingah PL; Muma G; Soubani A
Clin Transplant; 2014 Aug; 28(8):906-10. PubMed ID: 24931185
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.
Corris PA; Ryan VA; Small T; Lordan J; Fisher AJ; Meachery G; Johnson G; Ward C
Thorax; 2015 May; 70(5):442-50. PubMed ID: 25714615
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
Jain R; Hachem RR; Morrell MR; Trulock EP; Chakinala MM; Yusen RD; Huang HJ; Mohanakumar T; Patterson GA; Walter MJ
J Heart Lung Transplant; 2010 May; 29(5):531-7. PubMed ID: 20133163
[TBL] [Abstract][Full Text] [Related]
6. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Yadav H; Peters SG; Keogh KA; Hogan WJ; Erwin PJ; West CP; Kennedy CC
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2264-2269. PubMed ID: 27575542
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of azithromycin in bronchiolitis obliterans syndrome.
Gan CT; Ward C; Meachery G; Lordan JL; Fisher AJ; Corris PA
BMJ Open Respir Res; 2019; 6(1):e000465. PubMed ID: 31673366
[TBL] [Abstract][Full Text] [Related]
9. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR
J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268
[TBL] [Abstract][Full Text] [Related]
10. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB
Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648
[TBL] [Abstract][Full Text] [Related]
11. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
[TBL] [Abstract][Full Text] [Related]
12. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
[TBL] [Abstract][Full Text] [Related]
13. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
[TBL] [Abstract][Full Text] [Related]
14. Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome.
Fietta AM; Meloni F
Curr Med Chem; 2008; 15(7):716-23. PubMed ID: 18336286
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.
Verleden GM; Dupont LJ
Transplantation; 2004 May; 77(9):1465-7. PubMed ID: 15167610
[TBL] [Abstract][Full Text] [Related]
16. Home spirometry as early detector of azithromycin refractory bronchiolitis obliterans syndrome in lung transplant recipients.
de Wall C; Sabine D; Gregor W; Mark G; Axel H; Thomas F; Tobias W; Jens G
Respir Med; 2014 Feb; 108(2):405-12. PubMed ID: 24445061
[TBL] [Abstract][Full Text] [Related]
17. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
[TBL] [Abstract][Full Text] [Related]
18. Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin.
Mertens V; Blondeau K; Van Oudenhove L; Vanaudenaerde B; Vos R; Farre R; Pauwels A; Verleden G; Van Raemdonck D; Sifrim D; Dupont LJ
Am J Transplant; 2011 Feb; 11(2):329-35. PubMed ID: 21272237
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
